Tridek-One raises € 3 million from Advent France Biotechnology and Advent Life Sciences

Tridek One, Paris, June 4, 2019 – Tridek One, a biotech company specialized in the development of products for the treatment of immune disorders, is pleased to announce a first round of funding of 3 million euros with leading investors Advent France Biotechnology and Advent Life Sciences.

Continue reading “Tridek-One raises € 3 million from Advent France Biotechnology and Advent Life Sciences”